Literature DB >> 9744375

Malattia leventinese: refinement of the genetic locus and phenotypic variability in autosomal dominant macular drusen.

A O Edwards1, M L Klein, C B Berselli, J F Hejtmancik, K Rust, M K Wirtz, R G Weleber, T S Acott.   

Abstract

PURPOSE: To study the phenotypic variability in patients inheriting the disease gene for malattia leventinese (dominant macular drusen) and refine the localization of the gene.
METHODS: A family with dominant radial drusen was ascertained and studied with clinical examination and DNA linkage analysis. Inheritance of the disease gene was determined by DNA analysis and used to document the variability in phenotypic expression.
RESULTS: Fifty family members were studied with fundus photography and genotyping. Linkage analysis showed that the disease in this family was linked to chromosome 2p16-21 with a maximum lod score of 3.72 at D2S2153. An affected patient with obligate recombinations allowed refinement of the disease interval to a 6.2-cM region between D2S2227 and D2S378. The phenotype of older affected patients varied from severe geographic atrophy or subretinal fibrosis to a single druse adjacent to the optic disk. Small and medium-sized, nonradial, and soft macular drusen seen in four older individuals in the family were not specifically associated with the disease haplotype.
CONCLUSIONS: Refinement of the localization of the gene for malattia leventinese will facilitate its positional cloning. Genotypic documentation of the variable expression of the disease shows that a single, large, subretinal druse adjacent to the optic disk is consistent with inheritance of the disease gene. Soft macular drusen in low abundance were not specifically associated with inheritance of the disease gene. These results will facilitate the genetic counseling of patients with malattia leventinese. It is unknown what proportion of age-related macular degeneration arises from mutations in disease genes for dominant drusen.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9744375     DOI: 10.1016/s0002-9394(98)00097-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  7 in total

1.  Case of dominantly inherited drusen accompanied by choroidal neovascularization.

Authors:  Shuichi Yamamoto; Fumihiko Yagi; Mariko Kubota; Satoshi Mizunoya
Journal:  Jpn J Ophthalmol       Date:  2006 Jan-Feb       Impact factor: 2.447

2.  Benign Yellow Dot Maculopathy: A New Macular Phenotype.

Authors:  Arundhati Dev Borman; Aleksandra Rachitskaya; Martina Suzani; Robert A Sisk; Zubair M Ahmed; Graham E Holder; Valentina Cipriani; Gavin Arno; Andrew R Webster; Robert B Hufnagel; Audina Berrocal; Anthony T Moore
Journal:  Ophthalmology       Date:  2017-03-31       Impact factor: 12.079

Review 3.  Genetic susceptibility to age related macular degeneration.

Authors:  J R Yates; A T Moore
Journal:  J Med Genet       Date:  2000-02       Impact factor: 6.318

4.  Impaired cholesterol efflux in retinal pigment epithelium of individuals with juvenile macular degeneration.

Authors:  Yi-Ting Tsai; Yao Li; Joseph Ryu; Pei-Yin Su; Chia-Hua Cheng; Wen-Hsuan Wu; Yong-Shi Li; Peter M J Quinn; Kam W Leong; Stephen H Tsang
Journal:  Am J Hum Genet       Date:  2021-04-27       Impact factor: 11.025

5.  Molecular genetic heterogeneity in autosomal dominant drusen.

Authors:  E E Tarttelin; C Y Gregory-Evans; A C Bird; R G Weleber; M L Klein; J Blackburn; K Gregory-Evans
Journal:  J Med Genet       Date:  2001-06       Impact factor: 6.318

6.  A novel haplotype with the R345W mutation in the EFEMP1 gene associated with autosomal dominant drusen in a Japanese family.

Authors:  Tomokazu Takeuchi; Takaaki Hayashi; Matthew Bedell; Kang Zhang; Hisashi Yamada; Hiroshi Tsuneoka
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-22       Impact factor: 4.799

7.  First reported case of Doyne honeycomb retinal dystrophy (Malattia Leventinese/autosomal dominant drusen) in Scandinavia.

Authors:  Inger Norlyk Sheyanth; Ihab Bishara Lolas; Henrik Okkels; Ligor Pradeep Kiruparajan; Søren Kromann Abildgaard; Michael Bjørn Petersen
Journal:  Mol Genet Genomic Med       Date:  2021-03-10       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.